TLIS

Talis Biomedical Corporation Common Stock
TLIS

Overview Fund Activity
Delisted

TLIS was delisted on the 30th of August, 2024.

Back to rankings

27 hedge funds and large institutions have $5.6M invested in Talis Biomedical Corporation Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 6 closing their positions.

Holders
27
Holders Change
-2
Holders Change %
-6.9%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$42.3K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$8.64K
3
VF
3
Virtu Financial
New York
$5K
4
UBS Group
4
UBS Group
Switzerland
$3.04K
5
Jane Street
5
Jane Street
New York
$14.3K

Top Sellers

1
E
1
Ergoteles
New York
$0
2
ACH
2
ArrowMark Colorado Holdings
Colorado
$516K
3
Man Group
3
Man Group
United Kingdom
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$26.6K
5
Millennium Management
5
Millennium Management
New York
$49K
Name Holding Trade Value Shares
Change 		Shares
Change %
Man Group
26
Man Group
United Kingdom
– -$9K -873 Closed
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
– -$7K -671 Closed
TRCT
28
Tower Research Capital (TRC)
New York
– -$3K -280 Closed
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
– -$382 -37 Closed
1
2